Personas / Equipo Humano

Judith Usall I Rodié

Buscador de publicaciones

Publicaciones

  • Sánchez Autet M, Garriga M, Zamora FJ, González I, Usall J, Tolosa L, Benítez C, Puertas R and Arranz B.

    Screening of alcohol use disorders in psychiatric outpatients: influence of gender, age, and psychiatric diagnosis.

    Adicciones . 30(4): 251-263. Nº de citas: 4

    [doi:10.20882/adicciones.885]

  • Farreny A, Usall J, Cuevas-Esteban J, Ochoa S and Brebion G.

    Amendment of traditional assessment measures for the negative symptoms of schizophrenia.

    EUROPEAN PSYCHIATRY . 49: 50-55. Nº de citas: 3

    [doi:10.1016/j.eurpsy.2017.11.003]

  • Brebion G, Stephan-Otto C, Ochoa S, María de Lourdes Nieto García, Contel M and Usall J.

    Verbal fluency in male and female schizophrenia patients: Different patterns of association with processing speed, working memory span, and clinical symptoms.

    Neuropsychology . 32(1): 65-76. Nº de citas: 25

    [doi:10.1037/neu0000394]

  • Nuñez C, Theofanopoulou C, Carl Senior, Cambra-Martí MR, Usall J, Stephan-Otto C and Brebion G.

    A large-scale study on the effects of sex on gray matter asymmetry.

    BRAIN STRUCTURE & FUNCTION . 223(1): 183-193. Nº de citas: 13

    [doi:10.1007/s00429-017-1481-4]

  • Butjosa A, Gómez-Benito J, Myin-Germeys I, Barajas A, Baños I, Usall J, Grau N, Granell L, Sola A, Carlson J, Dolz M, Sánchez Fernández B, Haro JM, GENIPE group and Ochoa S.

    Development and validation of the Questionnaire of Stressful Life Events (QSLE).

    JOURNAL OF PSYCHIATRIC RESEARCH . 95: 213-223. Nº de citas: 9

    [doi:10.1016/j.jpsychires.2017.08.016]

  • Mezquida G, Cabrera B, Bioque M, Amoretti S, Lobo A, González-Pinto A, Espliego A, Corripio I, Vieta E, Castro-Fornieles J, Bergé D, Escartí MJ, Ibañez Á, Penadés R, Sánchez-Torres AM, Bernardo M and PEPs Group.

    The course of negative symptoms in first-episode schizophrenia and its predictors: A prospective two-year follow-up study.

    SCHIZOPHRENIA RESEARCH . 189: 84-90. Nº de citas: 37

    [doi:10.1016/j.schres.2017.01.047]

  • Huerta-Ramos ME, Marcó-García S, Escobar-Villegas MS, Rubio E, Ochoa S, Grasa Bello EM, Alonso Solís A, Rabella M, Berdun J, Hospedales M, M-Resist G, Corripio I and Usall J.

    m-RESIST, a complete m-Health solution for patients with treatmentresistant schizophrenia: a qualitative study of user needs and acceptability in the Barcelona metropolitan area.

    ACTAS ESPANOLAS DE PSIQUIATRIA . 45(6): 277-289. Nº de citas: 4

  • Esther Pousa Tomas, Ochoa S, Cobo JV, María de Lourdes Nieto García, Usall J, González B, Garcia-Ribera C, Pérez-Solà V, Ruiz A and Insight Barcelona Research Group.

    A deeper view of insight in schizophrenia: Insight dimensions, unawareness and misattribution of particular symptoms and its relation with psychopathological factors

    SCHIZOPHRENIA RESEARCH . 189: 61-68. Nº de citas: 26

    [doi:10.1016/j.schres.2017.02.016]

  • Puig O, Baeza I, de la Serna E, Cabrera B, Mezquida G, Bioque M, Lobo A, González-Pinto A, Parellada M, Corripio I, Vieta E, Bobes J, Usall J, Contreras F, Cuesta MJ, Bernardo M, Castro-Fornieles J and Group TP.

    Persistent Negative Symptoms in First-Episode Psychosis: Early Cognitive and Social Functioning Correlates and Differences Between Early and Adult Onset.

    JOURNAL OF CLINICAL PSYCHIATRY . 78(9): 1414-1422. Nº de citas: 26

    [doi:10.4088/JCP.16m11122]

  • Mas S, Gassó P, Torra M, Bioque M, Lobo A, González-Pinto A, Olmeda MS, Corripio I, Vieta E, Castro-Fornieles J, Rodriguez-Jimenez R, Bobes J, Usall J, Llerena A, Saiz-Ruiz J, Bernardo M, Lafuente A and PEPs Group.

    Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patients.

    EUROPEAN NEUROPSYCHOPHARMACOLOGY . 27(7): 647-656. Nº de citas: 9

    [doi:10.1016/j.euroneuro.2017.03.012]